Geneos Therapeutics has a total of 8 patents globally. Out of these 8 patents, more than 87% patents are active. The United States of America seems to be the main focused R&D center and also the origin country of Geneos Therapeutics.
Geneos Therapeutics was founded in the year 2016. Geneos Therapeutics is a biotechnology company. The company creates cancer immunotherapies that target neoantigens.
Do read about some of the most popular patents of Geneos Therapeutics which have been covered by us in this article and also you can find Geneos Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Geneos Therapeutics patent portfolio.
How many patents does Geneos Therapeutics have?
Geneos Therapeutics has a total of 8 patents globally. These patents belong to 1 unique patent family. Out of 8 patents, 7 patents are active.
How Many Patents did Geneos Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Geneos Therapeutics Applications Filed | Geneos Therapeutics Patents Granted |
| 2021 | 1 | – |
| 2020 | 2 | – |
| 2019 | 5 | – |
How many Geneos Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Geneos Therapeutics File in Different Countries?
Countries in which Geneos Therapeutics Filed Patents
| Country | Patents |
| Canada | 1 |
| Europe (EPO) | 1 |
| Hong Kong (S.A.R.) | 1 |
| India | 1 |
| Japan | 1 |
| Mexico | 1 |
| United States Of America | 1 |
Where are Research Centers of Geneos Therapeutics Patents Located?
The Research Centre for all the Geneos Therapeutics patents is the United States of America.
List of Geneos Therapeutics Patents
| Geneos Therapeutics Patents | Title |
| US20210361755A1 | Tumor-Specific Neoantigens And Methods Of Using The Same |
| EP3801597A4 | Tumor-Specific Neoantigens And Methods Of Using The Same |
| CA3100974A1 | Tumor-Specific Neoantigens And Methods Of Using The Same |
| JP2021525549A5 | Tumor-Specific Neoantigens And Methods Of Use Thereof |
| HK40048130A | Tumor-Specific Neoantigens And Methods Of Using The Same |
| IN202017048827A | Tumor-Specific Neoantigens And Methods Of Using The Same |
| MX2020012649A | Tumor-Specific Neoantigens And Methods Of Using The Same. |
| WO2019227106A9 | Tumor-Specific Neoantigens And Methods Of Using The Same |
What are Geneos Therapeutics key innovation segments?
What Technologies are Covered by Geneos Therapeutics?
The chart below distributes patents filed by Geneos Therapeutics